2017
DOI: 10.1038/s41598-017-15607-y
|View full text |Cite
|
Sign up to set email alerts
|

IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer

Abstract: Dysregulation of miRNAs is important in breast cancer initiation and malignant progression. Recently we showed that miR-152 downregulation is associated with breast cancer development, yet the underlying mechanism of miR-152 remains to be well elucidated. In this study, we identified β-catenin as a new direct target of miR-152. MiR-152 inhibited cell proliferation by targeting and inhibiting both β-catenin and PKM2 expression. We found that miR-152 expression sensitized the breast cancer cells to paclitaxel tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
19
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(21 citation statements)
references
References 46 publications
2
19
0
Order By: Relevance
“…In support of our results, the association between IGF-1 and miR-152 expression has been previously demonstrated in human oocytes, since the culturing of immature oocytes in the presence of IGF-1 signi cantly reduced the expression of miR-152 [47]. Moreover, in cancer research, it was suggested that miR-152 is involved in the IGF-1-mediated miR-152/PKM2/β-catenin regulatory circuit that regulates cell proliferation and angiogenesis [48]. Additionally, the overexpression of miR-152 inhibits breast cancer cell proliferation via targeting IGF1R and IRS1 and suppressing their downstream AKT and MAPK/ERK signaling pathways [37].…”
Section: Discussionsupporting
confidence: 89%
“…In support of our results, the association between IGF-1 and miR-152 expression has been previously demonstrated in human oocytes, since the culturing of immature oocytes in the presence of IGF-1 signi cantly reduced the expression of miR-152 [47]. Moreover, in cancer research, it was suggested that miR-152 is involved in the IGF-1-mediated miR-152/PKM2/β-catenin regulatory circuit that regulates cell proliferation and angiogenesis [48]. Additionally, the overexpression of miR-152 inhibits breast cancer cell proliferation via targeting IGF1R and IRS1 and suppressing their downstream AKT and MAPK/ERK signaling pathways [37].…”
Section: Discussionsupporting
confidence: 89%
“…Some microRNAs have organ specification, such as miRNA-122 [84], miRNA-124 [85], miRNA-133-3p [86], miRNA-137 [84], miRNA-20 [68] [4, 87] and miRNA-3662 [88] etc., which regulate the expression of PKM subunits by directly targeting polypyrimidine bundle binding protein 1 (PTBP1), while polypyrimidine bundle binding protein 1 (PTBP1) is a splice that regulates PKM2 dominant expression. Similar to: miRNA-29b [89], miRNA-99a [90], miRNA-133b [91], miRNA-145 [92], miRNA-148a [93], miRNA-152 [93, 94], miRNA-290 [95], miRNA-326 [96], miRNA-338-3P [97], miRNA-340 [98], miRNA-369 [99], miRNA-371 [95], miR-379 [100], miRNA-675 [101], miRNA-4417 etc. [102].…”
Section: The Splicing Of Pmk2mentioning
confidence: 99%
“…Arrays were deparaffinized, hydrated, pretreated for epitope unmasking, incubated with hydrogen peroxide, blocked with 10% goat serum (according to the manufacturer's instructions), and then arrays were incubated with the indicated antibodies at 4°C overnight. After washing, arrays were treated as previously reported ( 23 ).…”
Section: Methodsmentioning
confidence: 99%